June 30, 2004 - New drug to prevent lasting brain damage
Pharmos is focused on helping people think more clearly -- with cannabis. The biotechnology company is developing cannabis-related compounds that don't have psychotropic effects as potential treatments for central nervous system disorders. Pharmos' lead drug candidate, dexanabinol, is a neuroprotective compound that could prevent lasting damage from traumatic brain injury. It has received FDA fast track status for this indication. The drug candidate may also limit post-surgery memory loss and cognitive impairment. Other targets for these compounds include stroke, neuropathic pain, multiple sclerosis, and Alzheimer's disease.
The Gary Doehling Personal Injury Law Firm, P.C. handles the following types of cases: Automobile Accidents, Oil Field Accidents, Spinal Cord Injuries, Wrongful Death, Nursing Home Negligence, Cerebral Palsy, Traumatic Brain Injuries, Lead Paint Exposure, Toxic Molds, Medical Malpractice, Insurance Bad Faith Claims, Airplane Accidents, Dog Bites, Drunk Drivers, Large Truck Accidents, Motorcycle Accidents, School Bus Accidents, and Slip & Fall Accidents.
The Gary Doehling Personal Injury Law Firm, P.C. serves the following areas: Western Colorado, Eastern Utah, Grand Junction, Montrose, Glenwood Springs, Aspen, Delta, Hermosa, Western Slope, Moffat, Rio Blanco, Garfield, Ouray, San Miguel, Dolores, Montezuma, La Plata, San Juan, Daggett, Uintah, Grand.
The legal information offered by The Gary Doehling Personal Injury Law Firm and contained herein, regarding Colorado or Utah legal statutes and Colorado or Utah claimants' rights, is general in scope. No legal attorney / client relationship with our attorneys is hereby formed nor is the information herein intended as formal legal advice. Please contact a Colorado or Utah lawyer regarding your specific inquiry.See Terms of Use.
|
